drugset / Trial / NCT00236626

A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes

NCT00236626

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate (1) the effect of topiramate on insulin sensitivity in overweight or obese patients with type 2 diabetes mellitus and (2) the safety of topiramate in type 2 diabetic patients. The study will also investigate the effect of topiramate on body weight, body fat, fat distribution, and metabolic control including both glucose and lipid levels.

Timeline

Start
2000-04
Primary completion
Completion
2002-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 96 mg Oral
Subject Topiramate Small molecule 256 mg Oral